Lupin Seeks Anti-Obesity Drug Alliances While Aiming For No.2 Spot In Diabetes
In-Licensing Dynamics Are Changing
In an interview with Scrip, Lupin’s MD Nilesh Gupta spoke about seeking alliances to address the anti-obesity market in India post a demand surge for Wegovy and Mounjaro, the company’s thrust into pharma-adjacent businesses, the limited impact so far of the Israel-Palestine conflict on Indian pharma and more.
